Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3087)
All Articles published online
|
Mar 7, 2006 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Okabayashi T, Ichikawa K, Araki K. Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients. World J Gastroenterol 2006; 12(9): 1412-1415 [PMID: 16552811 DOI: 10.3748/wjg.v12.i9.1412] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/1412.htm |
| Number | Citing Articles |
| 1 |
Jun Kinoshita, Takahisa Yamaguchi, Hideki Moriyama, Sachio Fushida. Current status of conversion surgery for stage IV gastric cancer. Surgery Today 2021; 51(11): 1736 doi: 10.1007/s00595-020-02222-0
|
| 2 |
H. Ishigami, J. Kitayama, S. Kaisaki, A. Hidemura, M. Kato, K. Otani, T. Kamei, D. Soma, H. Miyato, H. Yamashita, H. Nagawa. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Annals of Oncology 2010; 21(1): 67 doi: 10.1093/annonc/mdp260
|
| 3 |
Satoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada. Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study. International Journal of Clinical Oncology 2011; 16(1): 57 doi: 10.1007/s10147-010-0135-9
|
| 4 |
Rai Shimoyama, Hirofumi Yasui, Narikazu Boku, Yusuke Onozawa, Shuichi Hironaka, Akira Fukutomi, Kentaro Yamazaki, Keisei Taku, Takashi Kojima, Nozomu Machida, Akiko Todaka, Hideharu Tomita, Takeshi Sakamoto, Takahiro Tsushima. Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin. Gastric Cancer 2009; 12(4): 206 doi: 10.1007/s10120-009-0524-9
|
| 5 |
Motohiro Imano, Atsushi Yasuda, Tatsuki Itoh, Takao Satou, Ying-Feng Peng, Hiroaki Kato, Masayuki Shinkai, Masahiro Tsubaki, Yasutaka Chiba, Takushi Yasuda, Haruhiko Imamoto, Shozo Nishida, Yoshifumi Takeyama, Kiyokata Okuno, Hiroshi Furukawa, Hitoshi Shiozaki. Phase II Study of Single Intraperitoneal Chemotherapy Followed by Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastasis. Journal of Gastrointestinal Surgery 2012; 16(12): 2190 doi: 10.1007/s11605-012-2059-3
|
| 6 |
Naoto Takahashi, Mitsuro Kanda, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Katsufumi Miyamoto, Yuichi Ito, Osamu Takayama, Motohiro Imano, Norio Mitsumori, Junichi Sakamoto, Satoshi Morita, Yasuhiro Kodera. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial. Gastric Cancer 2018; 21(6): 1014 doi: 10.1007/s10120-018-0817-y
|
| 7 |
Hiroyuki Arai, Eisuke Inoue, Kensei Yamaguchi, Narikazu Boku, Hiroki Hara, Tomohiro Nishina, Masahiro Tsuda, Kohei Shitara, Katsunori Shinozaki, Shinichiro Nakamura, Ichinosuke Hyodo, Kei Muro, Mitsuru Sasako, Masanori Terashima, Takako E. Nakajima. Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G. Cancer Medicine 2021; 10(21): 7673 doi: 10.1002/cam4.4303
|
| 8 |
Tomohisa Yamamoto, Tsutomu Fujii, Satoshi Hirano, Fuyuhiko Motoi, Goro Honda, Kenichiro Uemura, Joji Kitayama, Michiaki Unno, Yasuhiro Kodera, Hiroki Yamaue, Toshio Shimokawa, Daisuke Hashimoto, So Yamaki, Hideyuki Yoshitomi, Fumihiko Miura, Hideki Ueno, Mitsugu Sekimoto, Sohei Satoi. Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study). Trials 2022; 23(1) doi: 10.1186/s13063-022-06049-7
|
| 9 |
Yasushi Sekino, Yasuhiro Koyano, Yusuke Shimodaira, Yusuke Takahashi, Masao Okada, Kaori Hayashibara, Masahiro Sakon, Manabu Takata, Hitoshi Seki, Yasuhiro Munakata. Long-Term Survival for 8 Years of Peritoneal Recurrence of a Gastric Cancer Treated with S-1/docetaxel Combination Chemotherapy. The Japanese Journal of Gastroenterological Surgery 2018; 51(9): 566 doi: 10.5833/jjgs.2017.0158
|
| 10 |
Kanae Inoue, Koh Fukushi, Shota Yamaguchi, Tomonao Taira, Taro Shibuki, Tomoyuki Satake, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Masafumi Ikeda. Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. Pancreatology 2024; doi: 10.1016/j.pan.2024.03.015
|
| 11 |
Junzi Zhang, Zhaoxue Qi, Wenjie Ou, Xuguang Mi, Yanqiu Fang, Wenqi Zhang, Zhen Yang, Ying Zhou, Xiuying Lin, Junjie Hou, Zhixin Yuan. Advances in the treatment of malignant ascites in China. Supportive Care in Cancer 2024; 32(2) doi: 10.1007/s00520-023-08299-w
|
| 12 |
Junichi Sakamoto, Takanori Matsui, Yasuhiro Kodera. Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer 2009; 12(2): 69 doi: 10.1007/s10120-009-0505-z
|
| 13 |
Yasuhiro Kodera, Naoto Takahashi, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Yuichi Ito, Katsufumi Miyamoto, Osamu Takayama, Motohiro Imano, Daisuke Kobayashi, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto. Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial. Gastric Cancer 2017; 20(1): 190 doi: 10.1007/s10120-016-0598-0
|
| 14 |
Michiya Kobayashi, Akira Tsuburaya, Naoki Nagata, Yumi Miyashita, Koji Oba, Junichi Sakamoto. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer 2006; 9(2): 114 doi: 10.1007/s10120-006-0364-9
|
| 15 |
Nobuhiro Kurita, Mitsuo Shimada, Takashi Iwata, Masanori Nishioka, Shinya Morimoto, Kozo Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Toshihiro Nakao. Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer: phase I study. The Journal of Medical Investigation 2011; 58(1,2): 134 doi: 10.2152/jmi.58.134
|
| 16 |
Naminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, Takashi Sasaki, Hironori Ishigami, Hiroharu Yamashita, Hironori Yamaguchi, Tsuyoshi Hamada, Rie Uchino, Suguru Mizuno, Koji Miyabayashi, Dai Mohri, Kazumichi Kawakubo, Hirofumi Kogure, Natsuyo Yamamoto, Naoki Sasahira, Kenji Hirano, Hideaki Ijichi, Keisuke Tateishi, Minoru Tada, Joji Kitayama, Toshiaki Watanabe, Kazuhiko Koike. Intravenous and Intraperitoneal Paclitaxel with S-1 for Refractory Pancreatic Cancer with Malignant Ascites: an Interim Analysis. Journal of Gastrointestinal Cancer 2014; 45(3): 307 doi: 10.1007/s12029-014-9603-1
|
| 17 |
B. Frazier Taylor, Samuel C. McNeely, Heather L. Miller, J. Christopher States. Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization. Toxicology and Applied Pharmacology 2008; 230(2): 235 doi: 10.1016/j.taap.2008.02.030
|
| 18 |
Yasuomi Shimizu, Satoshi Tamada, Minoru Kato, Yukiyoshi Hirayama, Yuji Takeyama, Taro Iguchi, Marianne Sadar, Tatsuya Nakatani. Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. Journal of Clinical Medicine 2018; 7(11): 444 doi: 10.3390/jcm7110444
|
| 19 |
Yasunori Emi, Manabu Yamamoto, Ikuo Takahashi, Hiroyuki Orita, Yoshihiro Kakeji, Shunji Kohnoe, Yoshihiko Maehara. Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer. Surgery Today 2008; 38(11): 1013 doi: 10.1007/s00595-008-3769-8
|
| 20 |
Nan Liu, Yijie Zheng, Ying Zhu, Shudao Xiong, Yiwei Chu. Selective Impairment of CD4+CD25+Foxp3+Regulatory T cells by paclitaxel is explained by Bcl-2/Bax mediated apoptosis. International Immunopharmacology 2011; 11(2): 212 doi: 10.1016/j.intimp.2010.11.021
|
| 21 |
Akira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi, Shigefumi Yoshino, Masazumi Takahashi, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoto Takahashi, Hiroshi Imamura, Naokuni Tatsumoto, Akinori Hara, Kazuhiro Nishikawa, Ryoji Fukushima, Isao Nozaki, Hiroshi Kojima, Yumi Miyashita, Koji Oba, Marc Buyse, Satoshi Morita, Junichi Sakamoto. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. The Lancet Oncology 2014; 15(8): 886 doi: 10.1016/S1470-2045(14)70025-7
|
| 22 |
Shigeyuki Tamura, Hirofumi Miki, Kaoru Okada, Atsushi Takeno, Kumiko Uji, Atsuko Yoshida, Rei Suzuki, Shin Nakahira, Chiyomi Egawa, Ken Nakata, Shu Okamura, Keishi Sugimoto, Yuichi Takatsuka. Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer. Gastric Cancer 2010; 13(2): 101 doi: 10.1007/s10120-010-0547-2
|
| 23 |
Masayuki Kano, Koichi Hayano, Hideki Hayashi, Naoyuki Hanari, Hisashi Gunji, Takeshi Toyozumi, Kentaro Murakami, Masaya Uesato, Satoshi Ota, Hisahiro Matsubara. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis. Annals of Surgical Oncology 2019; 26(6): 1805 doi: 10.1245/s10434-019-07299-7
|
| 24 |
Thanigaivel Shanmugam, Nitin Joshi, Nadim Ahamad, Atul Deshmukh, Rinti Banerjee. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer. International Journal of Pharmaceutics 2020; 586: 119482 doi: 10.1016/j.ijpharm.2020.119482
|
| 25 |
Xin Zhang, Hejing Huang, Ziran Wei, Zhenxin Zhu, Dejun Yang, Hongbing Fu, Jiapeng Xu, Zunqi Hu, Yu Zhang, Qing You, Xin Huang, Ronglin Yan, Weimin Wang, Qingping Cai. <p>Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis</p>. Cancer Management and Research 2020; : 6641 doi: 10.2147/CMAR.S258360
|
| 26 |
Shen Zhao, Liyu Su, Yigui Chen, Xiaofeng Li, Peicheng Lin, Wujin Chen, Wenzheng Fang, Jinfeng Zhu, Hui Li, Liping Ren, Jie Liu, Yanni Hong, Shaowei Lin, Nanfeng Fan, Rongbo Lin. Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850242
|
| 27 |
Yu Mei, Min Shi, Zhenglun Zhu, Hong Yuan, Chao Yan, Chen Li, Tienan Feng, Min Yan, Jun Zhang, Zhenggang Zhu. Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer. Future Oncology 2022; 18(2): 139 doi: 10.2217/fon-2021-1020
|
| 28 |
Motohiro Imano, Kiyotaka Okuno. Treatment strategies for gastric cancer patients with peritoneal metastasis. Surgery Today 2014; 44(3): 399 doi: 10.1007/s00595-013-0603-8
|
| 29 |
Takahisa Yamaguchi, Sachio Fushida, Yasuhiko Yamamoto, Tomoya Tsukada, Jun Kinoshita, Katsunobu Oyama, Tomoharu Miyashita, Hidehiro Tajima, Itasu Ninomiya, Seiichi Munesue, Ai Harashima, Shinichi Harada, Hiroshi Yamamoto, Tetsuo Ohta. Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer. Oncology Reports 2017; 37(6): 3341 doi: 10.3892/or.2017.5586
|
| 30 |
Hiroharu Yamashita. Intraperitoneal Chemotherapy for Peritoneal Metastasis from Gastric Cancer. Journal of Nihon University Medical Association 2021; 80(6): 297 doi: 10.4264/numa.80.6_297
|
| 31 |
Hiromichi Maeda, Michiya Kobayashi, Junichi Sakamoto. Evaluation and treatment of malignant ascites secondary to gastric cancer. World Journal of Gastroenterology 2015; 21(39): 10936-10947 doi: 10.3748/wjg.v21.i39.10936
|
| 32 |
Shin Saito, Hironori Yamaguchi, Hideyuki Ohzawa, Hideyo Miyato, Rihito Kanamaru, Kentaro Kurashina, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama. Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases. Annals of Surgical Oncology 2021; 28(7): 3863 doi: 10.1245/s10434-020-09388-4
|
| 33 |
Naminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, Hironori Ishigami, Sohei Satoi, Suguru Mizuno, Hirofumi Kogure, Saburo Matsubara, Natsuyo Yamamoto, Hironori Yamaguchi, Minoru Tada, Joji Kitayama, Toshiaki Watanabe, Kazuhiko Koike. Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites. Investigational New Drugs 2016; 34(5): 636 doi: 10.1007/s10637-016-0369-0
|
| 34 |
Yasuo Hamamoto, Yongzhe Piao, Akitaka Makiyama. Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites. Gastric Cancer 2020; 23(3): 363 doi: 10.1007/s10120-020-01067-3
|
| 35 |
Takuya Kaneko, Kosuke Doki, Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Yoshiharu Suzuki, Masato Homma. Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review. Cancer Chemotherapy and Pharmacology 2022; 90(5): 421 doi: 10.1007/s00280-022-04479-3
|
| 36 |
Tadayoshi Hashimoto, Izuma Nakayama, Manabu Ohashi, Junki Mizusawa, Hiroshi Kawachi, Ryosuke Kita, Haruhiko Fukuda, Yukinori Kurokawa, Narikazu Boku, Takaki Yoshikawa, Masanori Terashima. Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer. Future Oncology 2023; 19(32): 2147 doi: 10.2217/fon-2023-0605
|
| 37 |
Brinda Rao Korivi, Silvana Faria, Asran Aly, Jia Sun, Madhavi Patnana, Corey T. Jensen, Nicolaus Wagner-Bartak, Priya R. Bhosale. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites. Clinical Imaging 2019; 56: 33 doi: 10.1016/j.clinimag.2019.03.002
|
| 38 |
JUNLI MA, HONG SHEN, LINDA KAPESA, SHAN ZENG. Lauren classification and individualized chemotherapy in gastric cancer. Oncology Letters 2016; 11(5): 2959 doi: 10.3892/ol.2016.4337
|
| 39 |
Tsutomu Namikawa, Keiichiro Yokota, Sachi Yamaguchi, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Masamitsu Kumon, Michiya Kobayashi, Kazuhiro Hanazaki. Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer. Oncology 2020; 98(7): 452 doi: 10.1159/000505973
|
| 40 |
Akira Tsuburaya, Naoki Nagata, Haruhiko Cho, Naoki Hirabayashi, Michiya Kobayashi, Hiroshi Kojima, Yasuhiro Munakata, Ryoji Fukushima, Yoichi Kameda, Tadakazu Shimoda, Koji Oba, Junichi Sakamoto. Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer. Cancer Chemotherapy and Pharmacology 2013; 71(5): 1309 doi: 10.1007/s00280-013-2130-0
|
| 41 |
Simon J. Hogg, John J. Evans, Peter H. Sykes, Kenny Chitcholtan. A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput format. Journal of Ovarian Research 2015; 8(1) doi: 10.1186/s13048-015-0172-0
|
| 42 |
Hiroki Hara, Shigenori Kadowaki, Masako Asayama, Akira Ooki, Toko Yamada, Takako Yoshii, Kensei Yamaguchi. First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake. International Journal of Clinical Oncology 2018; 23(2): 275 doi: 10.1007/s10147-017-1198-7
|
| 43 |
Ying‐Feng Peng, Motohiro Imano, Tatsuki Itoh, Takao Satoh, Yasutaka Chiba, Haruhiko Imamoto, Masahiro Tsubaki, Shozo Nishida, Takushi Yasuda, Hiroshi Furukawa. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S‐1 plus intravenous paclitaxel for serosa‐positive gastric cancer. Journal of Surgical Oncology 2015; 111(8): 1041 doi: 10.1002/jso.23928
|
| 44 |
Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, Ichinosuke Hyodo, Junki Mizusawa, Hiroki Hara, Tomohiro Nishina, Takeshi Sakamoto, Kohei Shitara, Katsunori Shinozaki, Hiroshi Katayama, Shinichiro Nakamura, Kei Muro, Masanori Terashima. Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G). Gastric Cancer 2020; 23(4): 677 doi: 10.1007/s10120-020-01043-x
|
| 45 |
Tetsuo Tani, Ichiro Nakachi, Shinnosuke Ikemura, Shigenari Nukaga, Keiko Ohgino, Aoi Kuroda, Hideki Terai, Keita Masuzawa, Taro Shinozaki, Kota Ishioka, Yohei Funatsu, Hidefumi Koh, Koichi Fukunaga, Kenzo Soejima. Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer. Cancer Management and Research 2021; : 7497 doi: 10.2147/CMAR.S330103
|
| 46 |
Yoshinao Ohbatake, Sachio Fushida, Tomoya Tsukada, Jun Kinoshita, Katsunobu Oyama, Hironori Hayashi, Tomoharu Miyashita, Hidehiro Tajima, Hiroyuki Takamura, Itasu Ninomiya, Masakazu Yashiro, Kousei Hirakawa, Tetsuo Ohta. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin. Clinical and Experimental Medicine 2016; 16(4): 585 doi: 10.1007/s10238-015-0387-9
|
| 47 |
Kunitoshi Shigeyasu, Shunsuke Kagawa, Futoshi Uno, Masahiko Nishizaki, Hiroyuki Kishimoto, Akira Gochi, Toshikazu Kimura, Takaomi Takahata, Yasuyuki Nonaka, Motoki Ninomiya, Toshiyoshi Fujiwara. Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination. Cancer Chemotherapy and Pharmacology 2013; 71(4): 937 doi: 10.1007/s00280-013-2086-0
|
| 48 |
Koji Kono, Wei-Peng Yong, Hirokazu Okayama, Asim Shabbir, Tomoyuki Momma, Shinji Ohki, Seiichi Takenoshita, Jimmy So. Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan. Gastric Cancer 2017; 20(S1): 122 doi: 10.1007/s10120-016-0660-y
|
| 49 |
Hiroshi Ono, Ryo Mafune, Taiyu Hayashi, Yasushi Misaki, Yukihiro Kaneko, Jumpei Saito, Miki Nagai, Hitoshi Kato. Paclitaxel-coated drug-eluting balloon for pulmonary vein stenosis after repair of total anomalous pulmonary venous return with asplenia. Journal of Cardiology Cases 2020; 22(3): 107 doi: 10.1016/j.jccase.2020.05.008
|
| 50 |
Haruhiko Imamoto, Koji Oba, Junichi Sakamoto, Hiroyasu Iishi, Hiroyuki Narahara, Takeyoshi Yumiba, Takashi Morimoto, Masaki Nakamura, Noboru Oriuchi, Chieko Kakutani, Satoshi Morita, Hitoshi Shiozaki. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer 2011; 14(1): 81 doi: 10.1007/s10120-011-0016-6
|
| 51 |
Masayuki Shinkai, Motohiro Imano, Yasutaka Chiba, Mitsuru Iwama, Osamu Shiraisi, Atsushi Yasuda, Masanobu Tsubaki, Shozo Nishida, Yutaka Kimura, Takushi Yasuda. Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S‐1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer. Journal of Surgical Oncology 2019; 119(1): 56 doi: 10.1002/jso.25295
|
| 52 |
Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges. Nanomedicine 2019; 14(10): 1323 doi: 10.2217/nnm-2018-0313
|
| 53 |
Joji Kitayama, Hironori Ishigami, Hironori Yamaguchi, Yasunaru Sakuma, Hisanaga Horie, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata. Treatment of patients with peritoneal metastases from gastric cancer. Annals of Gastroenterological Surgery 2018; 2(2): 116 doi: 10.1002/ags3.12060
|
| 54 |
Daisuke Kobayashi, Hironori Ishigami, Mitsuro Kanda, Chie Tanaka, Hironori Yamaguchi, Joji Kitayama, Yasuhiro Kodera. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis. Oncology 2020; 98(1): 48 doi: 10.1159/000502484
|
| 55 |
Satoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada. First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer. Gastric Cancer 2012; 15(1): 21 doi: 10.1007/s10120-011-0056-y
|